Walden Biosciences

Walden Biosciences

  • Founded: 2020
  • Location: Cambridge, MA
  • Employee range: 11 - 50
  • Clinical stage: Clin1
  • Therapy area: Kidney disease
  • Drug types: NPH, RAR
  • Lead product: WAL0921
  • Product link: https://www.waldenbiosciences.com/our-science/
  • Funding: $51M A Oct 2020


waldenbiosciences.com

linkedin.com

job board


Short description:

Podocyte-targeting Kidney Disease Treatments

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

Walden Biosciences is dedicated to transforming treatment of kidney disease through the development of highly specific, kidney targeted therapeutics. Their mission is to reverse disease progression and improve quality of life for kidney disease patients. Their scientific approach focuses on kidney cells called podocytes, which are implicated in most renal diseases. Their therapeutics are being developed to restore normal podocyte function, resulting in healthy kidney tissue. Another approach by Walden Biosciences is to inhibit an inflammatory molecule to reduce kidney inflammation, which leads to improved renal function. Walden is developing these breakthrough medicines for rare and prevalent forms of kidney disease.

Jobs:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com